About Vasta Bio-Informatics Private Limited
Data last updated: 22 December 2025
Vasta Bio-Informatics Private Limited is a private limited company based in Saidapet, Tamil Nadu, India, a subsidiary of Vasta Global Us Llc. The company specialises in business process outsourcing. Incorporated on 16 March 2016, the company has been in operation for over 10 years.
Registered with ROC Chennai under CIN U74900TN2016PTC173617.
Capital: an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.5 Cr. It is led by directors including Anurag Singh Mehta and Vinay Kumar Aggarwal.
Last AGM: 19 September 2025. Financial statements filed for year ended 31 March 2025. Office: 9Th Floor Campus 2 Rmz Millennia Business Park, Saidapet, Tamil Nadu.
As per the financials filed for FY 2023, the company reported a revenue of ₹87.4 Cr, a growth of 38.24% compared to the previous year.
The company has a workforce of approximately 1,197 employees as per the latest available data. It operates as a subsidiary of Vasta Global Us Llc.
The company is associated with 1 brand - Vasta Global.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vastaglobal.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered Address9Th Floor Campus 2 Rmz Millennia Business Park Ii, No. 143 Dr. Mgr Road Kandanchavadi Chennai, Saidapet, Tamil Nadu, India – 600096
-
IndustryBusiness Outsourcing, Business Process Outsourcing
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Vasta Bio-Informatics Private Limited
Vasta Bio-Informatics Private Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U74900TN2016PTC173617, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74900TN2016PTC173617 | Current |
| U74900KA2016PTC169123 | Previous |
| U74900MH2016PTC274500 | Previous |
Associated Brands with Vasta Bio-Informatics Private Limited
Vasta Bio-Informatics Private Limited operates one associated brand: Vasta Global. These brands represent Vasta Bio-Informatics Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Clinical research consulting services are offered globally. | vastaglobal.com |
Competitors & Alternatives of Vasta Bio-Informatics Private Limited
Brands and companies operating in the same space as Vasta Bio-Informatics Private Limited include S-Cubed, Blue Matter Consulting, PharmAla Biotech and 4 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
S-Cubed
|
Specialized consulting in clinical biometrics and regulatory affairs is provided. | Copenhagen, Denmark, Denmark | 2007 |
Blue Matter Consulting
|
Provider of consulting services focused for clinical drug development | San Francisco, United States, United States | 2012 |
PharmAla Biotech
|
Biomanufacturing, regulatory, and financial services are provided by PharmAla Biotech. | Toronto, Canada, Canada | 2021 |
MCRA
|
Provider of regulatory, quality assurance and market access services to biopharma sector | New York, United States, United States | 2004 |
Aptus Clinical
|
Auxiliary clinical development services are provided to biopharmaceutical firms. | Stockport, United Kingdom, United Kingdom | 2014 |
CATALIS
|
Consulting services for clinical drug development and trials are provided. | Montreal, Canada, Canada | 2017 |
CHDR
|
Early-stage clinical drug research consulting services are provided. | Leiden, Netherlands, Netherlands | 1987 |
Business Activity of Vasta Bio-Informatics Private Limited
Vasta Bio-Informatics Private Limited operates primarily in the information and communication sector. The company has 1 registered business activity segment, reflecting its diverse operational portfolio.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| ********* | Information and communication | ********* | Other information & communication service activities | ********* |
Auditor Details of Vasta Bio-Informatics Private Limited
Vasta Bio-Informatics Private Limited is audited by KARANIA & ASSOCIATES for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| KARANIA & ASSOCIATES | blur-value | blur-value | blur-value |
Board of Directors of Vasta Bio-Informatics Private Limited
Vasta Bio-Informatics Private Limited is currently managed by 4 directors, with 7 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anurag Singh Mehta | Director | 24 May 2022 | 4 Years 1 Months | Current |
| Vinay Kumar Aggarwal | Director | 12 Mar 2025 | 1 Years 3 Months | Current |
| Sumithra Gomatam | Director | 09 Jun 2022 | 4 Years 1 Months | Current |
| Narayanan Asuri | Director | 12 Mar 2025 | 1 Years 3 Months | Current |
Financials of Vasta Bio-Informatics Private Limited FY 2025 filings available
Vasta Bio-Informatics Private Limited reported revenue of ₹86.37 Cr (up 38.24% YoY) for FY 2023. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Vasta Bio-Informatics Private Limited
As of FY 2023, Vasta Bio-Informatics Private Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings Vasta Bio-Informatics Private Limited
Vasta Bio-Informatics Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Vasta Bio-Informatics Private Limited
Vasta Bio-Informatics Private Limited has a workforce of 1,197 employees as of Apr 01, 2024.
Employee Count & EPFO Data of Vasta Bio-Informatics Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Vasta Bio-Informatics Private Limited
GSTIN & GST Filing Data of Vasta Bio-Informatics Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Vasta Bio-Informatics Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Vasta Bio-Informatics Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Vasta Bio-Informatics Private Limited
MSME Payment Delays by Vasta Bio-Informatics Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Vasta Bio-Informatics Private Limited
Subsidiaries & Group Companies of Vasta Bio-Informatics Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Vasta Bio-Informatics Private Limited with ownership details.
MCA Filings & Documents of Vasta Bio-Informatics Private Limited
MCA Filings & Documents of Vasta Bio-Informatics Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Vasta Bio-Informatics Private Limited
Frequently Asked Questions about Vasta Bio-Informatics Private Limited
Vasta Bio-Informatics Private Limited is an active private limited company in the business outsourcing sector based in Saidapet, Tamil Nadu, India. It was incorporated on 16 March 2016 (10+ years old) and is registered under CIN U74900TN2016PTC173617. The company has 1,197 employees.
Vasta Bio-Informatics Private Limited reported revenue of ₹87.4 Cr for FY 2023 (up 38.24% YoY).
The current directors of Vasta Bio-Informatics Private Limited are:
The primary industry of Vasta Bio-Informatics Private Limited is business outsourcing. The company specifically operates in business process outsourcing. The company is currently active in this sector.
Vasta Bio-Informatics Private Limited can be reached at the registered office: 9Th Floor Campus 2 Rmz Millennia Business Park Ii, No. 143 Dr. Mgr Road Kandanchavadi Chennai, Saidapet, Tamil Nadu, India – 600096, or through the website vastaglobal.com.
The authorised capital is ₹1.5 Cr, and the paid-up capital is ₹1.5 Cr.